A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

Virginia Tech researchers have shown that memory loss in aging may be reversible. Using CRISPR tools, they corrected molecular disruptions in the hippocampus and amygdala, restoring memory in older ...

Emerging biotechnologies, strategic collaborations, and growing focus on personalized and regenerative medicine are accelerating the next wave of gene therapy innovation.Austin, Nov. 05, 2025 (GLOBE ...

VRTX's new drugs deliver a mixed Q3 performance. Alyftrek sales surge. Journavx and Casgevy lag expectations but show promise.

Aziz Ansari, an award-winning actor, director, writer and comedian, brings his “Hypothetical Tour” to the Gallo Center. He co ...

A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate ...

On November 6, 2025, Shanghai, China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology ...

Our new but simple method is far more effective and can now be applied to a much wider range of plant species than our ...

First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory multiple myeloma450 million cell dose is the recommended ...

Genetically modified organisms, also known as GMOs, have been a hot topic of conversation among researchers, producers, ...